Abound Wealth Management’s Integra LifeSciences IART Stock Holding History

Abound Wealth Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.07K	Hold	338	–	–	﹤0.01%	564
2026 Q1	$3.18K	Hold	338	–	–	﹤0.01%	819
2025 Q4	$4.2K	Hold	338	–	–	﹤0.01%	713
2025 Q3	$4.84K	Hold	338	–	–	﹤0.01%	650
2025 Q2	$4.15K	Hold	338	–	–	﹤0.01%	622
2025 Q1	$7.43K	Hold	338	–	–	﹤0.01%	458
2024 Q4	$7.67K	Hold	338	–	–	﹤0.01%	441
2024 Q3	$6.14K	Hold	338	–	–	﹤0.01%	509
2024 Q2	$9.85K	Hold	338	–	–	﹤0.01%	375
2024 Q1	$12K	Hold	338	–	–	﹤0.01%	337
2023 Q4	$14.7K	Hold	338	–	–	0.01%	320
2023 Q3	$12.9K	Hold	338	–	–	0.01%	292
2023 Q2	$13.9K	Hold	338	–	–	0.01%	283
2023 Q1	$19.4K	Hold	338	–	–	0.01%	211
2022 Q4	$19K	Hold	338	–	–	0.01%	197
2022 Q3	$14.3K	Buy	+338	New	+$17.3K	0.01%	235

Other funds holding IART

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

MAA

Mraz Amerine & Associates Modesto, California $697M AUM 19.37% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return

Abound Wealth Management's IART Position: Q2 2026 in Review

Abound Wealth Management held its Integra LifeSciences (IART) position steady in Q2 2026 at 338 shares worth $6.07K. The position accounts for ﹤0.01% of the portfolio, ranked #564.

Abound Wealth Management first reported a position in IART in Q3 2022 and has held it in 16 quarters since. The position peaked at $19.4K in Q1 2023. 16 funds tracked by Wall St. Rank hold IART as of Q2 2026.

Abound Wealth Management held 338 shares of Integra LifeSciences worth $6.07K as of Q2 2026.
Abound Wealth Management left its Integra LifeSciences share count unchanged in Q2 2026.
Integra LifeSciences made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #564 holding.
Abound Wealth Management first reported a position in Integra LifeSciences in Q3 2022 and has held it in 16 quarters since.
Abound Wealth Management's Integra LifeSciences position peaked at $19.4K in Q1 2023.
16 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.